Nature Cancer Profile Banner
Nature Cancer Profile
Nature Cancer

@NatureCancer

Followers
33,070
Following
302
Media
490
Statuses
2,142

Nature Cancer is a journal dedicated to publishing the latest advances across all areas of cancer research.

New York, USA
Joined January 2019
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@NatureCancer
Nature Cancer
13 days
ONLINE NOW – the @NatureCancer April issue! 🌺🌻🌷 Check out the content on #ferroptosis , #survivorship , #immunotherapy , #metabolism and more. And isn’t the cover puzzling 🧩? Find it here:
Tweet media one
0
1
14
@NatureCancer
Nature Cancer
4 years
🔴 WE HAVE SOMETHING TO CELEBRATE: OUR FIRST FULL ISSUE @NatureCancer IS LIVE ‼️ - GIVE US BIGGER CAPS TO SHOW OUR EXCITEMENT!! 🥳 🥳 Massive congrats to the team, and thanks to everyone that made this a reality. Stay tuned for our content:
Tweet media one
6
139
411
@NatureCancer
Nature Cancer
4 years
🔴Our first paper just published @NatureCancer ! Nabel &co report trispecific antibodies that engage multiple targets & induce enhanced tumor-cell killing. Links here: Free Access Paper: N&Vs @Nature : Enjoy! Stay tuned for more!!
Tweet media one
4
144
372
@NatureCancer
Nature Cancer
5 years
We are now open for submissions! Follow the link to submit your paper and get in touch if you’d like to learn more about the journal
4
114
235
@NatureCancer
Nature Cancer
5 years
📡Has anyone NOT seen this cool paper @NatureBiotech yet? The imaging is BEAUTIFUL😍 Ultra-bright biocompatible near-IR-IIb rare-earth nanoparticles to track immune checkpoint inhibition in vivo #NatureCancerPicks @Stanford @hdai32982194 LINK:
2
79
217
@NatureCancer
Nature Cancer
5 years
Hello twitterverse! #NatureCancer , the new journal in the @nature family, is here. Our mission is to embrace the breadth of #CancerResearch from basic preclinical to translational and clinical work across the natural, applied and social sciences
0
110
203
@NatureCancer
Nature Cancer
4 years
‼️ In our inaugural @NatureCancer issue, @KarunaMDPhD @LabMassague show a regenerative origin of CRC metastasis initiating cells. Check the paper and also N&Vs by SA.-Benitah! News&Views: Original Article: #cancer #metastasis
Tweet media one
0
117
187
@NatureCancer
Nature Cancer
1 year
✨DON’T MISS THIS @NatureCancer REVIEW ARTICLE – “Engineering-enhanced CAR T cells for improved cancer therapy” by #MichaelCMilone #JieXu #SaiJuanChen , #McKensieACollins #JianfengZhou @DJPowellLab & @j_melenhorst . Find it here👇
Tweet media one
0
52
189
@NatureCancer
Nature Cancer
2 years
🔥🔥 ONLINE NOW @NatureCancer : "The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response", by @IdoAmitLab @MiriamMerad #AmosTanay & Co Find it here!
Tweet media one
0
55
178
@NatureCancer
Nature Cancer
3 years
🔥The August issue @NatureCancer is out!🔥 Read about TLS and #immunotherapy in solid tumors, advances in #CART cell therapy, #TumorImmunology in prostate cancer, #chemotherapy and #leukemia relapse & more! Check the😍cover! Find the full issue 👇👇
Tweet media one
0
54
178
@NatureCancer
Nature Cancer
3 years
🔥🔥 ONLINE @NatureCancer : "Low #neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer", a very cool study by @LabJacks &Co Don't miss it!😎👇 #TumorImmunology #Immunotherapy
Tweet media one
Tweet media two
0
56
177
@NatureCancer
Nature Cancer
3 years
⚡️ONLINE NOW @NatureCancer : "Moving pan-cancer studies from basic research toward the clinic" - a fantastic Review by Li Ding & Co @WUSTLmed Don't miss it! 👇👇
Tweet media one
Tweet media two
0
61
164
@NatureCancer
Nature Cancer
3 years
⭐️ONLINE NOW @NatureCancer : Targeting immunosuppressive #macrophages overcomes #PARPinhibitor resistance in BRCA1-associated triple-negative #BreastCancer Don't miss this *fantastic* study by @JennGuerriero &Co! #TumorImmunology
Tweet media one
5
32
159
@NatureCancer
Nature Cancer
3 months
✨Our first @NatureCancer issue of 2024 is LIVE – check out the new content on #cancermetabolism in pancreatic cancer and glioblastoma, #metastatsis in prostate cancer and the #microbiome . Find it here👇
Tweet media one
5
40
158
@NatureCancer
Nature Cancer
1 year
☀️Just before the month is over – have a look at our @NatureCancer MAY ISSUE including exciting new science on #glioblastoma , #immunotherapy , #NSCLC & more. Check out our new article format #turningpoints and an editorial on the art of scientific writing.
Tweet media one
0
21
131
@NatureCancer
Nature Cancer
2 years
✨“A decade of CAR T cell evolution” – don’t miss this beautiful News & Views by @MarcelaMaus covering groundbreaking work by @MelenhorstLab @carlhjune @cdktmw & Co published in @Nature !
Tweet media one
0
52
128
@NatureCancer
Nature Cancer
1 year
🔥ONLINE NOW @NatureCancer “Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation” by @WischnewskiVlad @Johanna_A_Joyce & Co! #Braintumors #Tcells Read it here 👇
1
21
128
@NatureCancer
Nature Cancer
3 years
⭐️ONLINE NOW @NatureCancer : "Multi-omic profiling of peritoneal metastases in #GastricCancer identifies molecular subtypes and therapeutic vulnerabilities" by Tanaka, Mano, Yatabe &Co Don't miss it! 👇 #Metastasis #Therapy
Tweet media one
Tweet media two
Tweet media three
2
46
127
@NatureCancer
Nature Cancer
3 years
⚡️The "Milestones in Cancer" is out and is WONDERFUL. It covers key developments across cancer research in the last 20 years - coordinated by @SafiaDanovi and @SaheliSadanand with input from all cancer editors @NatResCancer The interactive timeline is🤩
0
55
125
@NatureCancer
Nature Cancer
4 years
⚡️Check out this beautiful paper @NatureCancer : Pan-cancer analysis of advanced/metastatic post-therapy patients reveals interactions between therapy and genomic landscapes, a new cohort by @mmarra0630 and co. Read it now:
Tweet media one
0
49
122
@NatureCancer
Nature Cancer
1 year
✨DON’T MISS THIS @NatureCancer REVIEW ARTICLE – “Advances in antibody-based therapy in oncology” by #DanielChrist & Co. #therapy Find it here👇
1
37
122
@NatureCancer
Nature Cancer
2 years
🔥🔥 ONLINE @NatureCancer : 2 studies from @yibinkang &Co discover MTDH-SND1 inhibitors for metast #BreastCancer therapy via cell- and non-cell-autonomous effects DON'T MISS THEM! 👇
Tweet media one
Tweet media two
4
42
120
@NatureCancer
Nature Cancer
5 months
💫ONLINE NOW @NatureCancer – the #2023Generation – 12 group leaders share their journey to becoming an independent PI. Very inspiring stories, please do not miss them!
Tweet media one
1
38
121
@NatureCancer
Nature Cancer
3 years
⭐️ONLINE @NatureCancer : The next generation of DNA methyltransferase inhibitors by @Pari_Mehdipour @rmzchen & @decarvalho_lab 👇👇 📑 Check the paper by Pappalardi &co @GSK too!
Tweet media one
0
34
117
@NatureCancer
Nature Cancer
4 years
⚡️Check our Issue2 Editorial @NatureCancer focused on AI in cancer ⚡️We also have a fantastic #Viewpoint in which we gathered six scientists to discuss challenges, hopes and hypes of #AI in cancer research, diagnosis and care.
Tweet media one
1
45
113
@NatureCancer
Nature Cancer
1 year
💫DON’T MISS our @NatureCancer April issue. Exciting content on #immunotherapy , #metastasis , #clinicaltrials , #ferroptosis and more – check it out here 👇👇👇
Tweet media one
2
25
111
@NatureCancer
Nature Cancer
4 years
ONLINE NOW @NatureCancer : "The T cell differentiation landscape is shaped by tumour mutations in lung #cancer " from the #TRACERx @QuezadaLab @SwantonLab -->And it comes with a beautiful cover!
Tweet media one
Tweet media two
0
55
114
@NatureCancer
Nature Cancer
3 years
🍂🎃Our October issue @NatureCancer IS LIVE! Read about #epigenetics drugs, #microbiota in HCC, #EGFR therapy resistance, neoantigens and #immune escape in CRC, #computational oncology, #macrophages in brain mets, #NKs and much more! DON'T MISS IT! 👇
Tweet media one
0
28
113
@NatureCancer
Nature Cancer
3 years
🔥 ONLINE NOW @NatureCancer : "Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide #PrecisionOncology " - a tour de force paper by @VanAllenLab &Co Don't miss it! 👇👇
Tweet media one
Tweet media two
1
39
112
@NatureCancer
Nature Cancer
2 years
🍂🌰🥧 Our November issue @NatureCancer IS LIVE! This month, read about RT and #Immunotherapy trials, #PancreaticCancer , macrophages & GBM therapy, SCC stemness, AML #metabolism and #therapy , #proteogenomics of lung cancer & much more! DON'T MISS IT! 👇
Tweet media one
2
30
105
@NatureCancer
Nature Cancer
2 years
⚡️Our January Issue IS LIVE! On to year three of @NatureCancer 🥳 Read about #metastasis , #therapy , tumor microenvironment & dormancy, ferroptosis, #pediatric brain tumor #immunotherapy and much more! Find it here:👇
Tweet media one
2
26
107
@NatureCancer
Nature Cancer
1 year
💫ONLINE NOW @NatureCancer - “Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction” by @andyjminn @jingya_qiu & Co. 👇
Tweet media one
0
35
104
@NatureCancer
Nature Cancer
3 years
🔥Two studies @NatureCancer and @Nature by @mvh_lab , #ToddGolub &Co show that fatty acid #metabolism is required for brain #metastasis Find them here! 👇 And the NVs by @almut_schulze &Co:
Tweet media one
Tweet media two
1
45
105
@NatureCancer
Nature Cancer
9 months
⭐️NEW ARTICLE @NatureCancer “CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis” by @EmilyCLerner @PeterFecci & Co. Don’t miss it👇
2
26
102
@NatureCancer
Nature Cancer
3 years
⭐️ICYMI @NatureCancer : "A #MachineLearning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types" by Paul F. Robbins &Co @theNCI Don't miss it! 👇👇 #cancer #Immunotherapy
Tweet media one
0
42
101
@NatureCancer
Nature Cancer
3 months
NEW REVIEW ARTICLE @NatureCancer – “Aneuploidy and complex genomic rearrangements in cancer evolution” by @VanLooLab #TobyMBaker #SaraWaise #MaximeTarabichi . Read it here👇
Tweet media one
1
41
100
@NatureCancer
Nature Cancer
4 years
⭐ONLINE NOW @NatureCancer : "Multimodal mapping of the tumor and peripheral blood immune landscape in human #PancreaticCancer " by @Pasca_Lab @HCCvPDAC @BednarLab & co - don't miss it! Read it here: #TumorImmunology #Cancer
Tweet media one
Tweet media two
3
25
100
@NatureCancer
Nature Cancer
2 years
12 early-career investigators across the globe 🌍 reflect on the challenges faced by their scientific communities in 2021 and highlight emerging opportunities. #2021InReview Read it👇
3
34
100
@NatureCancer
Nature Cancer
1 year
Happy International Women's Day #IWD2023 ! @NatureCancer supports #WomenInScience - please join us to celebrate some of the wonderful female scientists & clinicians who recently published their work with us – we hope you are inspired by them! 👩‍🔬
Tweet media one
1
13
99
@NatureCancer
Nature Cancer
3 years
🔥The July issue @NatureCancer is out, and it's just 😍 Read about #TherapyResistance and immune evasion, #EHR and #AI in oncology, #metabolism and immune suppression in glioma, #chromatin states in AML, #ClonalEvolution and much more! Find it here!👇
Tweet media one
3
27
95
@NatureCancer
Nature Cancer
2 years
Don’t miss the @NatureCancer 🍃OCTOBER 🍂ISSUE and read exciting new work on #metastasis in #breastcancer , the complement system in #immunotherapy , #machinelearning , #clinicaltrials and much more. Find it here👇
Tweet media one
2
27
96
@NatureCancer
Nature Cancer
1 year
@NatureCancer starts 2023 with exciting new studies – “Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer” by @RonDePinho & Co. 👇
0
21
93
@NatureCancer
Nature Cancer
4 years
🔴 Our second publication @NatureCancer is online! Led by @nlbigas and Abel Gonzalez-Perez - Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer @IRBBarcelona Read it here:
Tweet media one
4
38
92
@NatureCancer
Nature Cancer
6 months
Don’t miss our @NatureCancer OCTOBER ISSUE 🎃 This one features interesting articles on #glioblastoma therapy, #immunotherapy for AML, #immunometabolism , a Phase I #ClinicalTrial in ovarian cancer and more. Check it out here👇
Tweet media one
0
18
91
@NatureCancer
Nature Cancer
4 years
The August issue @NatureCancer is online and the cover is 😍 This month we have some studies about pan-cancer #DigitalPathology , #COVID19 and #cancer outcomes, #ClinicalGenomics , #Organoids , #microbiome & #medulloblastoma Check out the full content here:
Tweet media one
1
26
84
@NatureCancer
Nature Cancer
5 months
✨In our #2023InReview special we provide a collection of 12 research highlights summarizing impactful papers published in 2023 and present a collection of some of our most striking @NatureCancer publications. Check them out for some end-of-year reading.
Tweet media one
1
35
87
@NatureCancer
Nature Cancer
4 years
We just published a #CancerInTranslation piece @NatureCancer : "Microbiome genomics for cancer prediction" - check out this comment from @EranElinav and @TimGreten on a groundbreaking @nature paper by @KnightLabNews
Tweet media one
1
40
85
@NatureCancer
Nature Cancer
11 months
💫“Non-lethal outcomes of engaging regulated cell death pathways in cancer” – a perspective by #DouglasRGreen & Co. #celldeath Read it here👇
1
25
86
@NatureCancer
Nature Cancer
2 years
⭐️ONLINE NOW @NatureCancer : "Three-dimensional #ImagingMassCytometry for highly multiplexed molecular and cellular mapping of tissues and the #TumorMicroenvironment " - by @BodenmillerLab &Co @ETH_en @CancerGrand Check it out! 👉 👉
Tweet media one
0
34
87
@NatureCancer
Nature Cancer
1 year
☀️NEW REVIEW ONLINE NOW @NatureCancer „CD4+ T cells in cancer” – a beautiful summary by #DanielSpeiser #ChristinaM ünz & Co. Don’t miss it! Find it here👇
Tweet media one
0
21
85
@NatureCancer
Nature Cancer
1 year
✨DON’T MISS THIS @NatureCancer REVIEW ARTICLE – “YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches” by #StefanoPiccolo #TitoPanciera #PaoloContessotto & #MichelangeloCordenonsi . Find it here👇
Tweet media one
0
28
84
@NatureCancer
Nature Cancer
2 years
⭐️ONLINE NOW⭐️ @NatureCancer “A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology” by @AlanaWelm @BryanWelm &Co. Read it here:
1
22
82
@NatureCancer
Nature Cancer
1 year
💫NEW CONTENT @NatureCancer “The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer” by @michal_bassani & Co. Don't miss it👇
0
23
82
@NatureCancer
Nature Cancer
2 years
⭐️“Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma” by @obenaufa & Co @NatureCancer . Find it at: #February11 #WomenInScience @WomenScienceDay @UN_Women
Tweet media one
1
11
80
@NatureCancer
Nature Cancer
3 years
⭐️DON'T MISS our trifecta single-cell studies in #glioblastoma @NatureCancer - Iavarone & Co: - @PughLab &Co: - Piccolo & Co: +a *FAB* NVs by @JustinLathia to discuss them:
Tweet media one
2
45
80
@NatureCancer
Nature Cancer
1 year
✨DON’T MISS THIS @NatureCancer PERSPECTIVE – “Targeting public neoantigens for cancer immunotherapy” #ShibinZhou & Co. Find it here👇
Tweet media one
0
20
80
@NatureCancer
Nature Cancer
2 years
As part of our focus issue for #2021InReview Caroline Robert @GustaveRoussy provides a clinical outlook on checkpoint inhibition directed against LAG-3. Read it here 👇
0
26
79
@NatureCancer
Nature Cancer
4 years
🔴Our 3rd publication @NatureCancer is out! Ribas and co. show that PAK4 inhibition improves anti-PD-1 #cancer #immunotherapy by reducing Wnt activation and increasing TILs @UCLA @Parkerici Read here -> Stay tuned to our full launch in January!! 🥳 🥳
Tweet media one
0
20
76
@NatureCancer
Nature Cancer
2 years
🔥🔥 ONLINE NOW @NatureCancer : "A tumor-derived type III collagen-rich #ECM niche regulates tumor cell #dormancy ", a fantastic paper by @BravoCorderoLab &Co Don't miss this one! Links below 👇👇 #metastasis #TME
Tweet media one
1
29
77
@NatureCancer
Nature Cancer
4 years
⭐️ONLINE NOW @NatureCancer : A novel CD25 mAb depleting Tregs & preserving IL2 signaling in T effector cells enhances anti-tumor #immunity - by @QuezadaLab & Co. And a follow up trial launched already! Read it here: #Immunotherapy
Tweet media one
0
17
77
@NatureCancer
Nature Cancer
1 year
✨“Immunotherapy advances in cancers with mismatch repair or proofreading deficiencies” by @emilyalouani @BenjcRousseau #ThierryAndre and #AurelienMarabelle – as part of the @NatureCancer Focus Issue #2022InReview . Read it here👇
0
24
74
@NatureCancer
Nature Cancer
3 years
⭐️ONLINE NOW @NatureCancer : "Fatty acid synthesis is required for breast cancer brain metastasis", a fantastic work by Matt Vander Heiden @mvh_lab Rakesh Jain &Co. Don't miss it! #Cancer #Metabolism #metastasis
Tweet media one
0
20
74
@NatureCancer
Nature Cancer
3 years
⭐️ONLINE NOW @NatureCancer : "The #metabolic landscape of RAS-driven #cancer from biology to therapy" - a *fantastic* Review in our Cancer #Therapy Series by #FrankMcCormick and @mvh_lab labs Don't miss it!
Tweet media one
Tweet media two
1
23
73
@NatureCancer
Nature Cancer
3 years
🔥ONLINE NOW @NatureCancer : "Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in AML" By Pappalardi &Co @GSK 🔥Find it here! 👇👇 #Cancer #epigenetics #Therapy #AML
Tweet media one
Tweet media two
Tweet media three
0
21
72
@NatureCancer
Nature Cancer
4 years
🔴We are looking for an Associate or Senior Editor to join the #editorial team @NatureCancer If you are passionate about #science and have a PhD in #cancer research or a related field, have a look at the link below and feel free to reach out to us.
1
51
71
@NatureCancer
Nature Cancer
3 years
🔥ONLINE @NatureCancer : "The present and future of #PI3K inhibitors for #cancer therapy", a *fab* Review by #JeffEngelman @ScaltritiLab @castel_pau @EnedaToska 👉Part of our Series in Cancer Therapy!
Tweet media one
2
20
71
@NatureCancer
Nature Cancer
2 months
⭐️NEW CONTENT @NatureCancer “Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols” #immunotherapy
Tweet media one
0
25
71
@NatureCancer
Nature Cancer
2 years
✨The @NatureCancer April issue IS LIVE! Read about #therapy in lung cancer, concurrent delivery of #immunotherapy , mitochondrial fission in macrophages 🧫, #TumorMetabolism , #Metastasis and so much more! And don’t miss the beautiful cover! 👇👇
Tweet media one
0
14
68
@NatureCancer
Nature Cancer
5 years
First, @michelle_monje @humsav show that glioma cells interact with neurons through AMPA receptor synapses and non-synaptic potassium currents amplified by tumor-neuron gap junctions, promoting tumor progression @StanfordMed @Nature #NatureCancerPicks
1
27
69
@NatureCancer
Nature Cancer
3 years
⚡️ONLINE NOW @NatureCancer : "Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients" by @TreyIdeker Don't miss it!
Tweet media one
1
22
68
@NatureCancer
Nature Cancer
5 years
🔬 Three reports today @nature show that tumor cells can engage in synaptic connections with neurons, and this reciprocal interaction impacts the way brain tumors progress #NatureCancerPicks #thread 👇👇👇
Tweet media one
1
42
69
@NatureCancer
Nature Cancer
4 years
⚡️NEW CONTENT @NatureCancer : Todd Golub @broadinstitute and colleagues present the PRISM drug repurposing resource () to develop new #oncology #therapeutics with potential direct #clinical translation. Read it here:
Tweet media one
0
28
67
@NatureCancer
Nature Cancer
2 years
Happy International Women's Day #IWD2022 ! @NatureCancer supports #WomenInScience - please join us to celebrate some of the wonderful female scientists who recently published their work with us – we hope you are inspired by them! #BreakTheBias #InternationalWomensDay2022
Tweet media one
17
16
65
@NatureCancer
Nature Cancer
3 years
🤩Two #epigenetic #therapy papers for AML @NatureCancer ONLINE JUST NOW! 🔥Here is a NVs by Uli Steidl discussing implications, challenges and next steps in this important topic:
Tweet media one
1
23
64
@NatureCancer
Nature Cancer
4 years
⭐️ Read the latest review published @NatureCancer by Xiaoyang Zhang and @meyersonlab : "Illuminating the noncoding genome in cancer" Find it here: #noncoding #genomics #cancer
Tweet media one
0
26
63
@NatureCancer
Nature Cancer
3 years
💫 HAPPY ANNIVERSARY @NatureCancer 🥳 To celebrate this milestone we present an issue full of exciting research (), a curated collection of our articles () and a new article format, the Clinical Outlook! #OneYearOfNatureCancer
Tweet media one
2
12
63
@NatureCancer
Nature Cancer
3 years
🧬ICYMI: "Illuminating the noncoding genome in cancer", a Review by @meyersonlab and @xyzxiaoyang from our Series on #ClinicalCancerGenomics @NatureCancer Find it here! #NatureCancerHighlights #WeekendReads
Tweet media one
Tweet media two
2
28
64
@NatureCancer
Nature Cancer
4 years
⭐️The July @NatureCancer issue is out! Read about tumor #microbiota & intestinal inflammation; CAF heterogeneity in #BreastCancer ; immune modulation by PD-L1 from #DendriticCells ; NKs & polyclonal #metastasis ; and HCC #cancer #metabolism Read it here:
Tweet media one
2
11
63